1ob-methyl-13b-polycarbonalkylgon-4-en-3-ones
    2.
    发明授权
    1ob-methyl-13b-polycarbonalkylgon-4-en-3-ones 失效
    1-10B-METHYL-13B-聚碳酸二氢喹啉-4-烯-3-酮

    公开(公告)号:US3607889A

    公开(公告)日:1971-09-21

    申请号:US3607889D

    申请日:1966-05-19

    Abstract: 13-Aklyl-10-methylgon-4-en-3-ones possessing androgenic, anabolic, progestational activity are prepared from the correspondingly substituted 13-alkyl-10-methylgonan-4-ones wherein groups labile to mesylation are protected to permit selective mesylation of subsequently formed 4-hydroxy group, by converting the 4-one to its 3-hydroxy-methylene derivative, hydrolyzing the oximino group, mesylating the 4-hydroxy group, catalytically hydrogenating the unsaturation at the 4-position, and eliminating the 4-mexyloxy group to form the 4-en-3-one conjugated system.

    15-Ethynyl-11-deoxy PGE
    6.
    发明授权
    15-Ethynyl-11-deoxy PGE 失效
    15-乙炔基-11-脱氧PGE

    公开(公告)号:US3922302A

    公开(公告)日:1975-11-25

    申请号:US38300773

    申请日:1973-07-26

    Inventor: STRIKE DONALD P

    CPC classification number: C07D317/72 C07C405/00 Y10S514/826

    Abstract: 9-Oxo-15-substituted prostanoic acids, and intermediates for their preparation and for the preparation of other known prostaglandins are disclosed. The final products have bronchodilatory activity.

    Abstract translation: 公开了9-氧代-15-取代的前列腺酸及其制备和制备其它已知的前列腺素的中间体。 最终产品具有支气管扩张作用。

    11,15 Dimethyl-11 deoxy PGF{HD 2 {B
    7.
    发明授权
    11,15 Dimethyl-11 deoxy PGF{HD 2 {B 失效
    11,15二甲基-11脱氧PGF {HD 2 {

    公开(公告)号:US3919302A

    公开(公告)日:1975-11-11

    申请号:US44683574

    申请日:1974-02-28

    CPC classification number: C07C405/00

    Abstract: The topical application of 7-(5 Alpha -hydroxy-2 Beta -((3RS)-3hydroxy-3-methyl-trans-1-octenyl)-3 Alpha -methyl-1 Alpha cyclopentyl)-cis-6-heptenoic acid, 7-(5 Alpha -hydroxy-2 Beta ((3RS)-3-hydroxy-3-methyl-trans-1-octenyl)-1 Alpha -cyclopentyl)cis-5-heptenoic acid, or 7-(2 Beta -((3RS)-hydroxy-3-methyltrans-1-octenyl)-5-oxo-1 Alpha -cyclopentyl)-cis-5-heptenoic acid to a wound surface can be employed to attenuate bleeding. The compounds are prepared from the prostaglandin PGA2.

    Abstract translation: 7-(5α-羟基-2β - [(3RS)-3-羟基-3-甲基 - 反-1-辛烯基]-3α-甲基-1α-环戊基) - 顺式-6- 庚烯酸,7-(5α-羟基-2β - [(3RS)-3-羟基-3-甲基 - 反-1-辛烯基]-1α-环戊基) - 顺式-5-庚烯酸或7- (2β-[(3RS) - 羟基-3-甲基 - 反-1-辛烯基] -5-氧代-1α-环戊基) - 顺式-5-庚烯酸可以用于减少出血。 该化合物由前列腺素PGA2制备。

Patent Agency Ranking